NCT04675372View on ClinicalTrials.gov

Dexmedetomidine Facilitate Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 3, 2021

Conditions
Lower Limb FractureNerve Block
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine group (Group D) was given 1.5ug/kg/h Dexmedetomidine continuous infusion

DRUG

Midazolam

Midazolam group (Group M) was continuously pumped with 0.05mg/kg/h midazolam

Trial Locations (1)

100053

China International Neuroscience, Beijing

All Listed Sponsors
lead

China International Neuroscience Institution

OTHER

NCT04675372 - Dexmedetomidine Facilitate Analgesia | Biotech Hunter | Biotech Hunter